{"id":"W2242211041","doi":"10.1200/jco.2007.25.18_suppl.lba4509","title":"Phase III study of gemcitabine [G] plus cetuximab [C] versus gemcitabine in patients [pts] with locally advanced or metastatic pancreatic adenocarcinoma [PC]: SWOG S0205 study","year":2007,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":187,"is_retracted":false,"has_abstract":true,"ca_institutions":"CancerCare Manitoba","funders":"","keywords":"Medicine; Gemcitabine; Internal medicine; Cetuximab; Clinical endpoint; Hazard ratio; Pancreatic cancer; Oncology; Performance status; Phases of clinical research; Chemotherapy; Randomization; Cancer; Clinical trial; Confidence interval; Colorectal cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002581745,0.001483368,0.002509666,0.0003951721,0.0003755281,0.001029813,0.0009022313,0.0012789,0.004248196],"category_scores_gemma":[0.0013263,0.0006322644,0.00199092,0.0005882453,0.0008312672,0.0007025389,0.0003865521,0.002713233,0.0009092517],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001197138,"about_ca_system_score_gemma":0.002234715,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001747009,"about_ca_topic_score_gemma":0.004564476,"domain_scores_codex":[0.999241,0.0005313422,0.00004039046,0.00006884882,0.0000440624,0.00007442033],"domain_scores_gemma":[0.9990403,0.0001829445,0.0001926255,0.00004879438,0.00005126918,0.0004841284],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.929614,0.02438667,0.006912261,0.0005196771,0.001629193,0.0001035103,0.0001175135,0.001593517,0.005440621,0.0001371941,0.002664347,0.02688152],"study_design_scores_gemma":[0.7733737,0.209708,0.01210448,0.00004835168,0.0008184355,0.0001036314,0.00004852449,0.001458695,0.000712946,0.0001162309,0.0014862,0.00002088259],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.992137,0.001565203,0.0004634408,0.0006528387,0.0001945398,0.002503351,0.0009873111,0.0000613389,0.00143509],"genre_scores_gemma":[0.9872295,0.001887923,0.001582071,0.002046079,0.0002528208,0.002613738,0.001963598,0.00002688969,0.002397374],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004248196,"threshold_uncertainty_score":0.01421165,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1550207843786884,"score_gpt":0.5070348059410741,"score_spread":0.3520140215623857,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}